Target intelligence / Profile preview

Intestinal epithelial glycocalyx

Molecular classification
Glycoproteins, Proteoglycans, Glycolipids, Supramolecular complex
01

Overview

The intestinal epithelial glycocalyx is a negatively charged (anionic), carbohydrate-rich layer comprised mainly of membrane-bound glycoproteins (mucins), proteoglycans, and glycolipids, located on the apical surface of intestinal epithelial cells. Its principal biological functions include serving as a diffusion barrier and initial defense against microbial pathogens and toxins, mediating cell–cell recognition and adhesion, and regulating the uptake and digestion of nutrients by concentrating digestive enzymes at the epithelial surface. The anionic character is derived from the numerous negatively charged sugar moieties, especially glycosaminoglycan chains (e.g., heparan sulfate, hyaluronic acid). This structure is also the primary site for adhesion of commensal bacteria and plays an essential role in forming the intestinal barrier and shaping the gut microbiota. Unlike classical drug targets such as receptors or enzymes, the glycocalyx is a dynamic supramolecular structure whose integrity and composition can be influenced by diet (e.g., oligosaccharides, prebiotics). Alterations or breakdown of the glycocalyx are implicated in increased susceptibility to infection and inflammatory disorders in the gut.

Other names
Glycocalyxintestinal glycocalyxbrush border glycocalyxepithelial glycocalyx
02

Mechanism of action

No classic mechanism; dietary/probiotic compounds may modulate structure, barrier, and microbiota interaction

03

Biological functions

Barrier to pathogens and toxinsInitial site of commensal bacteria adhesionRegulation of nutrient absorption/digestionRegulation of ionic and macromolecular accessCell–cell recognitionProtection against physical trauma
04

Disease associations

InfectionInflammatory bowel diseaseDigestive/absorptive disorders
05

Safety considerations

Integrity breakdown may increase infection risk and inflammationShedding or alteration may affect absorption and contribute to susceptibility to GI disease
06

Interacting drugs

Human milk oligosaccharides

2 more in the full profile.

Beyond the preview

Go deeper on Intestinal epithelial glycocalyx.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Intestinal epithelial glycocalyx.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call